_id
690f3b5cccc777a4e85d19b8
Ticker
CASBF
Name
CanSino Biologics Inc
Exchange
PINK
Address
401-420, Biomedical Park, Tianjin, China, 300457
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.cansinotech.com
Description
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.
Last Close
4.745
Volume
-
Current Price
4.745
Change
0
Last Updated
2026-01-02T10:55:21.573Z
Image
-
Ipo Date
-
Market Cap
2278260224
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
43542583
Cost Of Revenue
9419036
Gross Profit
34123547
Operating Expenses
34061252
Operating Income
62295
Interest Expense
1559386
Pretax Income
3900499
Net Income
3919411
Eps
0.01585788561595251
Dividends Per Share
-
Shares Outstanding
132670900
Income Tax Expense
-18912
EBITDA
5490665
Operating Margin
0.1430668456209867
Total Other Income Expense Net
3838204
Cash
151629508
Short Term Investments
194772115
Receivables
103575104
Inventories
50239374
Total Current Assets
553030302
Property Plant Equipment
369316897
Total Assets
1025048240
Payables
7213737
Short Term Debt
51246068
Long Term Debt
-
Total Liabilities
332711445
Equity
692336794
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
4340132
Capital Expenditures
6442567
Cash From Investing
-8221892
Cash From Financing
-66911522
Net Change In Cash
-9980097
Cf_currency_symbol
-
PE
-
PB
1.693925595510095
ROE
0.5661133474295749
ROA
0.382363565640579
FCF
-2102435
Fcf Percent
-0.04828457236907604
Piotroski FScore
4
Health Score
52
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
8
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
43542583
Quarters > 0 > income Statement > cost Of Revenue
9419036
Quarters > 0 > income Statement > gross Profit
34123547
Quarters > 0 > income Statement > operating Expenses
34061252
Quarters > 0 > income Statement > operating Income
62295
Quarters > 0 > income Statement > interest Expense
1559386
Quarters > 0 > income Statement > pretax Income
3900499
Quarters > 0 > income Statement > net Income
3919411
Quarters > 0 > income Statement > eps
0.01585788561595251
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
247158486
Quarters > 0 > income Statement > income Tax Expense
-18912
Quarters > 0 > income Statement > EBITDA
5490665
Quarters > 0 > income Statement > operating Margin
0.1430668456209867
Quarters > 0 > income Statement > total Other Income Expense Net
3838204
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
151629508
Quarters > 0 > balance Sheet > short Term Investments
194772115
Quarters > 0 > balance Sheet > receivables
103575104
Quarters > 0 > balance Sheet > inventories
50239374
Quarters > 0 > balance Sheet > total Current Assets
553030302
Quarters > 0 > balance Sheet > property Plant Equipment
369316897
Quarters > 0 > balance Sheet > total Assets
1025048240
Quarters > 0 > balance Sheet > payables
7213737
Quarters > 0 > balance Sheet > short Term Debt
51246068
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
332711445
Quarters > 0 > balance Sheet > equity
692336794
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
3919411
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
4340132
Quarters > 0 > cash Flow > capital Expenditures
6442567
Quarters > 0 > cash Flow > cash From Investing
-8221892
Quarters > 0 > cash Flow > cash From Financing
-66911522
Quarters > 0 > cash Flow > net Change In Cash
-9980097
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.01585788561595251
Quarters > 0 > ratios > PB
1.693925595510095
Quarters > 0 > ratios > ROE
0.5661133474295749
Quarters > 0 > ratios > ROA
0.382363565640579
Quarters > 0 > ratios > FCF
-2102435
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
-0.04828457236907604
Quarters > 0 > health Score
52
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
245169344
Quarters > 1 > income Statement > cost Of Revenue
54743575
Quarters > 1 > income Statement > gross Profit
190425769
Quarters > 1 > income Statement > operating Expenses
193098369
Quarters > 1 > income Statement > operating Income
-3355375
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-372237
Quarters > 1 > income Statement > net Income
-1939979
Quarters > 1 > income Statement > eps
-0.006288266460461157
Quarters > 1 > income Statement > dividends Per Share
12392621
Quarters > 1 > income Statement > shares Outstanding
308507760
Quarters > 1 > income Statement > income Tax Expense
-105644
Quarters > 1 > income Statement > EBITDA
12742958
Quarters > 1 > income Statement > operating Margin
-1.3685948435706545
Quarters > 1 > income Statement > total Other Income Expense Net
2983138
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1128406000
Quarters > 1 > balance Sheet > short Term Investments
321257500
Quarters > 1 > balance Sheet > receivables
660325856
Quarters > 1 > balance Sheet > inventories
339753882
Quarters > 1 > balance Sheet > total Current Assets
4334838425
Quarters > 1 > balance Sheet > property Plant Equipment
2647302019
Quarters > 1 > balance Sheet > total Assets
7705027156
Quarters > 1 > balance Sheet > payables
46237419
Quarters > 1 > balance Sheet > short Term Debt
1015117634
Quarters > 1 > balance Sheet > long Term Debt
864431000
Quarters > 1 > balance Sheet > total Liabilities
2801623486
Quarters > 1 > balance Sheet > equity
4903403666
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
-1939979
Quarters > 1 > cash Flow > depreciation
82888000
Quarters > 1 > cash Flow > change In Working Capital
-9635157
Quarters > 1 > cash Flow > cash From Operations
25078568
Quarters > 1 > cash Flow > capital Expenditures
67023387
Quarters > 1 > cash Flow > cash From Investing
151838094
Quarters > 1 > cash Flow > cash From Financing
-100534429
Quarters > 1 > cash Flow > net Change In Cash
72316670
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
-0.006288266460461157
Quarters > 1 > ratios > PB
0.29854146648182567
Quarters > 1 > ratios > ROE
-0.039563926042877826
Quarters > 1 > ratios > ROA
-0.025178094258750464
Quarters > 1 > ratios > FCF
-41944819
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.17108508884373408
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
137160578
Quarters > 2 > income Statement > cost Of Revenue
23743792
Quarters > 2 > income Statement > gross Profit
113416786
Quarters > 2 > income Statement > operating Expenses
129899647
Quarters > 2 > income Statement > operating Income
-16482861
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-16594619
Quarters > 2 > income Statement > net Income
-11545430
Quarters > 2 > income Statement > eps
-0.05
Quarters > 2 > income Statement > dividends Per Share
13025715
Quarters > 2 > income Statement > shares Outstanding
230908600
Quarters > 2 > income Statement > income Tax Expense
5049190
Quarters > 2 > income Statement > EBITDA
27955390
Quarters > 2 > income Statement > operating Margin
-12.017200015007228
Quarters > 2 > income Statement > total Other Income Expense Net
-111758
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3088268396
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
665932535
Quarters > 2 > balance Sheet > inventories
322559055
Quarters > 2 > balance Sheet > total Current Assets
4134286325
Quarters > 2 > balance Sheet > property Plant Equipment
2636191092
Quarters > 2 > balance Sheet > total Assets
7820387399
Quarters > 2 > balance Sheet > payables
56746050
Quarters > 2 > balance Sheet > short Term Debt
857585729
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2921615153
Quarters > 2 > balance Sheet > equity
4898772250
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-11545430
Quarters > 2 > cash Flow > depreciation
46355208
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-13801882
Quarters > 2 > cash Flow > capital Expenditures
67364221
Quarters > 2 > cash Flow > cash From Investing
-437359085
Quarters > 2 > cash Flow > cash From Financing
-46365792
Quarters > 2 > cash Flow > net Change In Cash
-500136449
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.05
Quarters > 2 > ratios > PB
0.2236603889882817
Quarters > 2 > ratios > ROE
-0.23568007269576577
Quarters > 2 > ratios > ROA
-0.14763245618083223
Quarters > 2 > ratios > FCF
-81166103
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.591759703724783
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
279260105
Quarters > 3 > income Statement > cost Of Revenue
116473927
Quarters > 3 > income Statement > gross Profit
162786178
Quarters > 3 > income Statement > operating Expenses
315178162
Quarters > 3 > income Statement > operating Income
-152391984
Quarters > 3 > income Statement > interest Expense
22519
Quarters > 3 > income Statement > pretax Income
-155499806
Quarters > 3 > income Statement > net Income
-156474583
Quarters > 3 > income Statement > eps
-0.6279537930562897
Quarters > 3 > income Statement > dividends Per Share
14515488
Quarters > 3 > income Statement > shares Outstanding
249181683
Quarters > 3 > income Statement > income Tax Expense
974777
Quarters > 3 > income Statement > EBITDA
-174858565
Quarters > 3 > income Statement > operating Margin
-54.569908580389594
Quarters > 3 > income Statement > total Other Income Expense Net
-3107822
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2022519453
Quarters > 3 > balance Sheet > short Term Investments
1639023000
Quarters > 3 > balance Sheet > receivables
737621939
Quarters > 3 > balance Sheet > inventories
283414609
Quarters > 3 > balance Sheet > total Current Assets
4282490711
Quarters > 3 > balance Sheet > property Plant Equipment
2640858991
Quarters > 3 > balance Sheet > total Assets
7958132228
Quarters > 3 > balance Sheet > payables
62473685
Quarters > 3 > balance Sheet > short Term Debt
900778909
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3048260568
Quarters > 3 > balance Sheet > equity
4909871654
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-156474583
Quarters > 3 > cash Flow > depreciation
216829930
Quarters > 3 > cash Flow > change In Working Capital
-78863555
Quarters > 3 > cash Flow > cash From Operations
120127376
Quarters > 3 > cash Flow > capital Expenditures
131608298
Quarters > 3 > cash Flow > cash From Investing
658432214
Quarters > 3 > cash Flow > cash From Financing
-101280937
Quarters > 3 > cash Flow > net Change In Cash
686875866
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.6279537930562897
Quarters > 3 > ratios > PB
0.24081425527116232
Quarters > 3 > ratios > ROE
-3.1869383565764386
Quarters > 3 > ratios > ROA
-1.966222456689746
Quarters > 3 > ratios > FCF
-11480922
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.041111930399080815
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
824884000
Annuals > 0 > income Statement > cost Of Revenue
244432000
Annuals > 0 > income Statement > gross Profit
580452000
Annuals > 0 > income Statement > operating Expenses
983842000
Annuals > 0 > income Statement > operating Income
-403390000
Annuals > 0 > income Statement > interest Expense
59982000
Annuals > 0 > income Statement > pretax Income
-381204000
Annuals > 0 > income Statement > net Income
-378884000
Annuals > 0 > income Statement > eps
-1.534856777110264
Annuals > 0 > income Statement > dividends Per Share
63780995
Annuals > 0 > income Statement > shares Outstanding
246853000
Annuals > 0 > income Statement > income Tax Expense
2467000
Annuals > 0 > income Statement > EBITDA
-109839000
Annuals > 0 > income Statement > operating Margin
-48.902633582418865
Annuals > 0 > income Statement > total Other Income Expense Net
22186000
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
1556463000
Annuals > 0 > balance Sheet > short Term Investments
1639023000
Annuals > 0 > balance Sheet > receivables
793301000
Annuals > 0 > balance Sheet > inventories
280522000
Annuals > 0 > balance Sheet > total Current Assets
4282491000
Annuals > 0 > balance Sheet > property Plant Equipment
2656953000
Annuals > 0 > balance Sheet > total Assets
7958132000
Annuals > 0 > balance Sheet > payables
62474000
Annuals > 0 > balance Sheet > short Term Debt
902159000
Annuals > 0 > balance Sheet > long Term Debt
1098538000
Annuals > 0 > balance Sheet > total Liabilities
3048260000
Annuals > 0 > balance Sheet > equity
4909872000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
-381204000
Annuals > 0 > cash Flow > depreciation
211383000
Annuals > 0 > cash Flow > change In Working Capital
-115790000
Annuals > 0 > cash Flow > cash From Operations
-168787000
Annuals > 0 > cash Flow > capital Expenditures
457638000
Annuals > 0 > cash Flow > cash From Investing
3962000
Annuals > 0 > cash Flow > cash From Financing
-334184000
Annuals > 0 > cash Flow > net Change In Cash
-490294000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
-1.534856777110264
Annuals > 0 > ratios > PB
0.23856375176379344
Annuals > 0 > ratios > ROE
-7.71677958203391
Annuals > 0 > ratios > ROA
-4.760966518273384
Annuals > 0 > ratios > FCF
-626425000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.7594098079245082
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
345182000
Annuals > 1 > income Statement > cost Of Revenue
1221201000
Annuals > 1 > income Statement > gross Profit
-876019000
Annuals > 1 > income Statement > operating Expenses
1159163000
Annuals > 1 > income Statement > operating Income
-2035182000
Annuals > 1 > income Statement > interest Expense
64145000
Annuals > 1 > income Statement > pretax Income
-1978884000
Annuals > 1 > income Statement > net Income
-1482732000
Annuals > 1 > income Statement > eps
-6.009998716392178
Annuals > 1 > income Statement > dividends Per Share
3628000
Annuals > 1 > income Statement > shares Outstanding
246710868
Annuals > 1 > income Statement > income Tax Expense
-11451149
Annuals > 1 > income Statement > EBITDA
-1645686000
Annuals > 1 > income Statement > operating Margin
-589.596792416754
Annuals > 1 > income Statement > total Other Income Expense Net
56298000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
2046998000
Annuals > 1 > balance Sheet > short Term Investments
2072967000
Annuals > 1 > balance Sheet > receivables
636882259
Annuals > 1 > balance Sheet > inventories
352847638
Annuals > 1 > balance Sheet > total Current Assets
5180828000
Annuals > 1 > balance Sheet > property Plant Equipment
3013446664
Annuals > 1 > balance Sheet > total Assets
9318769000
Annuals > 1 > balance Sheet > payables
103970000
Annuals > 1 > balance Sheet > short Term Debt
1459498000
Annuals > 1 > balance Sheet > long Term Debt
1065660000
Annuals > 1 > balance Sheet > total Liabilities
4031354000
Annuals > 1 > balance Sheet > equity
5274604094
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-1978884000
Annuals > 1 > cash Flow > depreciation
269053000
Annuals > 1 > cash Flow > change In Working Capital
-156955000
Annuals > 1 > cash Flow > cash From Operations
-908227507
Annuals > 1 > cash Flow > capital Expenditures
610470104
Annuals > 1 > cash Flow > cash From Investing
-449645859
Annuals > 1 > cash Flow > cash From Financing
-7582093
Annuals > 1 > cash Flow > net Change In Cash
-1345169000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-6.009998716392178
Annuals > 1 > ratios > PB
0.22193951390430178
Annuals > 1 > ratios > ROE
-28.11077331257234
Annuals > 1 > ratios > ROA
-15.911243212488687
Annuals > 1 > ratios > FCF
-1518697611
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-4.399701059151404
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1031041000
Annuals > 2 > income Statement > cost Of Revenue
1217648000
Annuals > 2 > income Statement > gross Profit
-186607000
Annuals > 2 > income Statement > operating Expenses
1182135000
Annuals > 2 > income Statement > operating Income
-1368742000
Annuals > 2 > income Statement > interest Expense
41341000
Annuals > 2 > income Statement > pretax Income
-1184001000
Annuals > 2 > income Statement > net Income
-909431000
Annuals > 2 > income Statement > eps
-3.6853945490082656
Annuals > 2 > income Statement > dividends Per Share
193932000
Annuals > 2 > income Statement > shares Outstanding
246766252
Annuals > 2 > income Statement > income Tax Expense
-219244000
Annuals > 2 > income Statement > EBITDA
-1318848154
Annuals > 2 > income Statement > operating Margin
-132.7534016590999
Annuals > 2 > income Statement > total Other Income Expense Net
184741000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
3394824000
Annuals > 2 > balance Sheet > short Term Investments
2551967000
Annuals > 2 > balance Sheet > receivables
1084400000
Annuals > 2 > balance Sheet > inventories
677777000
Annuals > 2 > balance Sheet > total Current Assets
7730185000
Annuals > 2 > balance Sheet > property Plant Equipment
3083144000
Annuals > 2 > balance Sheet > total Assets
11468960000
Annuals > 2 > balance Sheet > payables
253120000
Annuals > 2 > balance Sheet > short Term Debt
1624335000
Annuals > 2 > balance Sheet > long Term Debt
878008000
Annuals > 2 > balance Sheet > total Liabilities
4223358000
Annuals > 2 > balance Sheet > equity
6748090000
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
-1184001000
Annuals > 2 > cash Flow > depreciation
196360000
Annuals > 2 > cash Flow > change In Working Capital
-1478956000
Annuals > 2 > cash Flow > cash From Operations
-1887599000
Annuals > 2 > cash Flow > capital Expenditures
1075013000
Annuals > 2 > cash Flow > cash From Investing
-1227641000
Annuals > 2 > cash Flow > cash From Financing
854602000
Annuals > 2 > cash Flow > net Change In Cash
-2064188000
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
-3.6853945490082656
Annuals > 2 > ratios > PB
0.17351663444619145
Annuals > 2 > ratios > ROE
-13.476865305590174
Annuals > 2 > ratios > ROA
-7.929498402645052
Annuals > 2 > ratios > FCF
-2962612000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.873418224881455
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4299702000
Annuals > 3 > income Statement > cost Of Revenue
1296486000
Annuals > 3 > income Statement > gross Profit
3003216000
Annuals > 3 > income Statement > operating Expenses
1201354000
Annuals > 3 > income Statement > operating Income
1940795000
Annuals > 3 > income Statement > interest Expense
20419000
Annuals > 3 > income Statement > pretax Income
1936787000
Annuals > 3 > income Statement > net Income
1914390000
Annuals > 3 > income Statement > eps
7.736472014548394
Annuals > 3 > income Statement > dividends Per Share
14098000
Annuals > 3 > income Statement > shares Outstanding
247450000
Annuals > 3 > income Statement > income Tax Expense
29701000
Annuals > 3 > income Statement > EBITDA
1849176000
Annuals > 3 > income Statement > operating Margin
45.1378956029976
Annuals > 3 > income Statement > total Other Income Expense Net
-4008000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5456873000
Annuals > 3 > balance Sheet > short Term Investments
2326033000
Annuals > 3 > balance Sheet > receivables
157926000
Annuals > 3 > balance Sheet > inventories
875621000
Annuals > 3 > balance Sheet > total Current Assets
9289844000
Annuals > 3 > balance Sheet > property Plant Equipment
2218305000
Annuals > 3 > balance Sheet > total Assets
11874187000
Annuals > 3 > balance Sheet > payables
842567000
Annuals > 3 > balance Sheet > short Term Debt
1111969000
Annuals > 3 > balance Sheet > long Term Debt
40000000
Annuals > 3 > balance Sheet > total Liabilities
3326303000
Annuals > 3 > balance Sheet > equity
7995046000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
1907086000
Annuals > 3 > cash Flow > depreciation
88542000
Annuals > 3 > cash Flow > change In Working Capital
84308000
Annuals > 3 > cash Flow > cash From Operations
2014557000
Annuals > 3 > cash Flow > capital Expenditures
1203136000
Annuals > 3 > cash Flow > cash From Investing
-2531270000
Annuals > 3 > cash Flow > cash From Financing
1559922000
Annuals > 3 > cash Flow > net Change In Cash
1009427000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
7.736472014548394
Annuals > 3 > ratios > PB
0.1468597241341701
Annuals > 3 > ratios > ROE
23.944702757182384
Annuals > 3 > ratios > ROA
16.12228272975657
Annuals > 3 > ratios > FCF
811421000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.1887156365720229
Annuals > 3 > health Score
92
Valuation > metrics > PE
0.01585788561595251
Valuation > metrics > PB
1.693925595510095
Valuation > final Score
100
Valuation > verdict
49.9% Undervalued
Profitability > metrics > ROE
0.5661133474295749
Profitability > metrics > ROA
0.7087154150189767
Profitability > metrics > Net Margin
0.09001328653378235
Profitability > final Score
17
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4805629974939625
Risk > metrics > Interest Coverage
0.0399484155943429
Risk > final Score
60
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.46000935172466
Liquidity > metrics > Quick Ratio
8.600626156724266
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
47
Prev Risks > 1
47
Prev Risks > 2
-27021
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:33:34.276Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.31
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-27
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0158
Earnings History > 1 > eps Estimate
-0.01
Earnings History > 1 > eps Difference
0.0258
Earnings History > 1 > surprise Percent
258
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-20
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0011
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0064
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.088
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-29
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CNY
Earnings History > 5 > eps Actual
0.0017
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-28
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
CNY
Earnings History > 6 > eps Actual
-0.0309
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-04-29
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
-0.0957
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
CNY
Earnings History > 8 > eps Actual
-0.2785
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-09-30
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
-0.0802
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-06-30
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
-0.4047
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
-0.0827
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-26
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
-1.78
Earnings History > 12 > eps Estimate
0.72
Earnings History > 12 > eps Difference
-2.5
Earnings History > 12 > surprise Percent
-347.2222
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-10-28
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
-0.2875
Earnings History > 13 > eps Estimate
0.84
Earnings History > 13 > eps Difference
-1.1275
Earnings History > 13 > surprise Percent
-134.2262
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-26
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
-0.0668
Earnings History > 14 > eps Estimate
0.73
Earnings History > 14 > eps Difference
-0.7968
Earnings History > 14 > surprise Percent
-109.1507
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-28
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
0.0774
Earnings History > 15 > eps Estimate
0.73
Earnings History > 15 > eps Difference
-0.6526
Earnings History > 15 > surprise Percent
-89.3973
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-25
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
2.31
Earnings History > 16 > eps Estimate
1.92
Earnings History > 16 > eps Difference
0.39
Earnings History > 16 > surprise Percent
20.3125
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-10-28
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
1.6
Earnings History > 17 > eps Estimate
2.87
Earnings History > 17 > eps Difference
-1.27
Earnings History > 17 > surprise Percent
-44.2509
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-27
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
3.85
Earnings History > 18 > eps Estimate
7.04
Earnings History > 18 > eps Difference
-3.19
Earnings History > 18 > surprise Percent
-45.3125
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-29
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
-0.06
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.06
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-02-25
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
-0.0092
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0092
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-10-27
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
-0.1375
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.1375
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-21
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
-0.0467
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.0467
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CNY
Earnings History > 23 > eps Actual
-0.0525
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.0525
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-27
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
CNY
Earnings History > 24 > eps Actual
-0.0141
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0141
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CNY
Earnings History > 25 > eps Actual
-0.0422
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0422
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-22
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
CNY
Earnings History > 26 > eps Actual
-0.0154
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0154
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CNY
Earnings History > 27 > eps Actual
-0.016
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.016
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CNY
Earnings History > 28 > eps Actual
-0.0412
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.0412
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CNY
Earnings History > 29 > eps Actual
-0.0413
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0413
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CNY
Earnings History > 30 > eps Actual
-0.0254
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.0254
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CNY
Earnings History > 31 > eps Actual
-0.0268
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.0268
Earnings History > 31 > surprise Percent
-
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFosun Pharmaceutical, CanSino Take Different Paths As Covid Lift Fade Seeking Alpha
Read more →StockWatch: FDA Panel’s Rebuff on Cancer mAb Hammers Y-mAbs Shares Genetic Engineering and Biotechnology News
Read more →Showing 2 of 3
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of CanSino Biologics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.31
Date
2025-09-30
EPS Actual
0.0158
EPS Estimate
-0.01
EPS Difference
0.0258
Surprise Percent
258%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.